Citation Tools

Download PDFPDF

P16 Implications of nice guidance in england and wales on eligibility for treatment with mepolizumab and omalizumab – an ideal study analysis
Free

Download to a citation manager

Cite this article as:
Hartmann C, Camejo HS, Gunsoy N, et al
P16 Implications of nice guidance in england and wales on eligibility for treatment with mepolizumab and omalizumab – an ideal study analysis